Studies in IBD indicate an increased concentration of dietary n-3 PUFA is associated with reduced inflammation and improved disease activity.12,31 While no significant association was observed in our cohort between dietary or erythrocyte membrane n-3 PUFAs with CRP or fecal calprotectin, a notable limitation in our study is the patient population with mild systemic inflammation (CRP <5 mg/L). Here, CRP is linked to inflammatory bowel disease.